| Identification | Back Directory | [Name]
Cilostazol-d11 | [CAS]
89332-50-3 | [Synonyms]
OPC013015
Pletal-d11
Brn 3632107
Cilostazolum
OPC-13013-d11
Cilostazol-d11
CILOSTAZOL METABOLITE
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinon
2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-
2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro- | [Molecular Formula]
C20H16D11N5O2 | [MDL Number]
MFCD00866780 | [MOL File]
89332-50-3.mol | [Molecular Weight]
380.528 |
| Chemical Properties | Back Directory | [Appearance]
Colourless Needles | [Melting point ]
159-160°C | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Methanol (Slightly, Sonicated) | [form ]
Solid | [color ]
White to Off-White | [CAS DataBase Reference]
89332-50-3 |
| Hazard Information | Back Directory | [Chemical Properties]
Colourless Needles | [Uses]
A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo | [Definition]
ChEBI: Cilostazol is a lactam that is 3,4-dihydroquinolin-2(1H)-one in which the hydrogen at position 6 is substituted by a 4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy group. It has a role as a bronchodilator agent, a vasodilator agent, a fibrin modulating drug, a platelet aggregation inhibitor, a neuroprotective agent, an anticoagulant and an EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor. It is a member of tetrazoles and a lactam. |
|
|